Amphastar Pharmaceuticals (AMPH) Earnings Date, Estimates & Call Transcripts → Urgent Nvidia Warning (From Altimetry) (Ad) Free amph Stock Alerts $42.46 -0.20 (-0.47%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 8After Market ClosesConfirmedActual EPS (Feb. 28) $0.81 Missed By -$0.03 Consensus EPS (Feb. 28) $0.84 Get Amphastar Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for AMPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Amphastar Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.72$0.72$0.72Q2 20241$0.72$0.72$0.72Q3 20241$1.01$1.01$1.01Q4 20241$1.03$1.03$1.03FY 20244$3.48$3.48$3.48AMPH Earnings Date and InformationAmphastar Pharmaceuticals last posted its quarterly earnings data on February 28th, 2024. The reported $0.81 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.84 by $0.03. The business earned $178.11 million during the quarter, compared to analysts' expectations of $174.90 million. Amphastar Pharmaceuticals has generated $2.58 earnings per share over the last year ($2.58 diluted earnings per share) and currently has a price-to-earnings ratio of 16.5. Earnings for Amphastar Pharmaceuticals are expected to grow by 18.18% in the coming year, from $3.41 to $4.03 per share. Amphastar Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Amphastar Pharmaceuticals will be holding an earnings conference call on Wednesday, May 8th at 5:00 PM Eastern. Interested parties can register for or listen to the call.. Read More Amphastar Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)------- 2/28/2024Q4 2023$0.84$0.81($0.03)$0.94$174.90 million$178.11 million11/8/2023Q3 2023$0.67$1.08+$0.41$1.25$170.65 million$180.56 million8/8/2023Q2 2023$0.52$0.58+$0.06$0.67$137.20 million$145.71 million5/9/2023Q1 2023$0.40$0.52+$0.12$0.54$130.50 million$140.02 million2/28/2023Q4 2022$0.34$0.67+$0.33$0.68$126.43 million$135.02 million11/7/2022Q3 2022$0.32$0.32-$0.34$126.20 million$120.13 million Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022$0.30$0.33+$0.03$0.33$118.17 million$123.47 million 5/9/2022Q1 2022$0.33$0.47+$0.14$0.47$110.60 million$120.37 million 3/10/2022Q4 2021$0.38$0.42+$0.04$0.45$111.38 million$120.89 million 11/8/2021Q3 2021$0.24$0.46+$0.22$0.33$103.00 million$112.20 million 8/8/2021Q2 2021$0.21$0.21-$0.26$101.38 million$101.66 million 5/6/2021Q1 2021$0.19$0.27+$0.08$0.44$97.12 million$103.02 million Amphastar Pharmaceuticals Earnings - Frequently Asked Questions When is Amphastar Pharmaceuticals's earnings date? Amphastar Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on AMPH's earnings history. Did Amphastar Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Amphastar Pharmaceuticals (NASDAQ:AMPH) missed the analysts' consensus estimate of $0.84 by $0.03 with a reported earnings per share (EPS) of $0.81. Learn more on analysts' earnings estimate vs. AMPH's actual earnings. How much revenue does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $644.40 million. How much profit does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $137.54 million. AMPH has generated $2.58 earnings per share over the last four quarters. What is Amphastar Pharmaceuticals's price-to-earnings ratio? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 16.46 and a forward price-to-earnings ratio of 12.45. The price/earnings-to-growth ratio is 1.02. What is Amphastar Pharmaceuticals's EPS forecast for next year? Amphastar Pharmaceuticals's earnings are expected to grow from $3.41 per share to $4.03 per share in the next year, which is a 18.18% increase. More Earnings Resources from MarketBeat Related Companies: Avidity Biosciences Earnings Results Keros Therapeutics Earnings Results PTC Therapeutics Earnings Results Maravai LifeSciences Earnings Results Galapagos Earnings Results Geron Earnings Results Rocket Pharmaceuticals Earnings Results Vera Therapeutics Earnings Results Dyne Therapeutics Earnings Results TG Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:AMPH) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.